Education Events

Join us for an exclusive virtual recap of the latest breakthroughs in brain cancer research and treatment emerging presented at the 7th World Federation of Neuro-Oncology Societies (WFNOS) and 30th Society for Neuro-Oncology(SNO) Meetings in Honolulu, Hawaii. This webinar will highlight the most impactful updates with a focus on clinical relevance and research trends. Speakers attending the event and expert panel will explore the latest findings with an Australian lens. Stay tuned for the video recording, available to all COGNO members.

Hosted by the COGNO Outreach and Education Committee, this session will highlight the most impactful updates with a focus on clinical relevance and research trends. Our expert panel discussion will explore how the new international data impacts patient care at home. Join us for a focused webinar exploring the latest developments in brain cancer research and treatment, presented at one of the most influential oncology conferences — the 2025 ASCO (American Society of Clinical Oncology) Annual Meeting. This session will highlight the most impactful updates with a focus on clinical relevance and research trends.

Gliomas are the most common form of brain cancer in Australia. Implementing effective early detection and management strategies is essential to improving outcomes and enhancing the quality of life for those affected. This masterclass aims to provide clinicians and trainees with an in-depth, multidisciplinary understanding of current and emerging strategies in the management of low-grade glioma (LGG), with a focus on IDH-mutant gliomas, through expert-led lectures and interactive case-based discussions.

Join local neuro-oncology experts for a review of the latest and most significant international treatment and research findings in brain cancer presented at this year’s Society for Neuro-Oncology Meeting in Houston, Texas. Our expert panel will review the latest in translational science, and clinical updates in low grade glioma and glioblastoma. Drawing on a panel of clinicians and scientist from across Australia, this is a great opportunity to hear their perspectives on how these advances may impact brain cancer care in Australia.